Leaflet BYANNLI 1000mg long-release injection suspension


Indicated for: schizophrenia; bipolar disorder

Substance: paliperidone (antipsychotic)

ATC: N05AX13 (Nervous system | Antipsychotics | Other antipsychotics)

Paliperidone is an antipsychotic medication used for the treatment of schizophrenia and schizoaffective disorder. It belongs to the class of atypical antipsychotics and works by regulating the activity of neurotransmitters in the brain, such as dopamine and serotonin.

The medication is administered orally or as long-acting injectable formulations, as directed by your doctor. It is important to follow the prescribed dosage and not to discontinue treatment without consulting your doctor.

Side effects may include drowsiness, dizziness, weight gain, gastrointestinal disturbances, or, in rare cases, neuroleptic malignant syndrome.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as cardiovascular diseases or diabetes, to ensure the safe use of paliperidone.

General data about BYANNLI 1000mg

  • Substance: paliperidone
  • Date of last drug list: 01-05-2026
  • Commercial code: W68386001
  • Concentration: 1000mg
  • Pharmaceutical form: long-release injection suspension
  • Quantity: 1
  • Product type: original
  • Price: 6648.92 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: JANSSEN PHARMACEUTICA N.V. - BELGIA
  • Holder: JANSSEN CILAG INTERNATIONAL NV - BELGIA
  • Number: 1453/2020/008
  • Shelf life: 2 years

Concentrations available for paliperidone

  • 1000mg
  • 100mg
  • 12mg
  • 150mg
  • 175mg
  • 25mg
  • 263mg
  • 350mg
  • 3mg
  • 50mg
  • 525mg
  • 6mg
  • 700mg
  • 75mg
  • 9mg

Compensation lists for BYANNLI 1000mg Cilag

G15 (C1) - Mental disorders

Price

Copayment

Patient

6648.92 RON

6648.92 RON

0.00 RON